Rockwell Medical (STU:RWM) Tariff Resilience Score: 6/10 (As of Jul. 05, 2026)


STU:RWM Rockwell Medical Inc STU:RWM
26 GF Score
Price €4.80
GF Value €0.82
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Rockwell Medical Tariff Resilience Score?

Rockwell Medical STU:RWM 26 Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus rates STU:RWM with a GF Score™ of 26/100 and a GF Value™ of €0.82 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,028 Drug Manufacturers companies, Rockwell Medical ranks better than 91.05% on this metric.

Rockwell Medical has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Rockwell Medical has Medical products company with some exposure to tariffs on raw materials. Mitigation through alternative suppliers and strong domestic market presence.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Rockwell Medical might have Average Resilient.

Rockwell Medical  (STU:RWM) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Rockwell Medical Tariff Resilience Score Related Terms

STU:RWM vs CPHI, TXMD, MRMD: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rockwell Medical Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Tariff Resilience Score falls into.


STU:RWM
26GF Score
Rockwell Medical Inc STU:RWM
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Rockwell Medical (STU:RWM) has a Tariff Resilience Score of 6 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Rockwell Medical ranks #92 out of 1028 companies in the Drug Manufacturers industry, placing it in the top 8.9%.
Is Rockwell Medical's Tariff Resilience Score too high?
Rockwell Medical's current Tariff Resilience Score is 6. Based on the distribution chart, Rockwell Medical ranks #92 out of 1028 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Rockwell Medical has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's Tariff Resilience Score compare to CPHI and TXMD?
According to the Drug Manufacturers industry distribution chart, Rockwell Medical ranks #92 out of 1028 companies for Tariff Resilience Score. This places Rockwell Medical in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Rockwell Medical's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (STU:RWM) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.82, compared to a current price of €4.80 — trading 485.4% above its estimated fair value. The current Tariff Resilience Score is 6. Rockwell Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Rockwell Medical (STU:RWM), the current Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rockwell Medical (STU:RWM) Overvalued in 2026?

Based on GuruFocus' analysis, Rockwell Medical stock appears to be overvalued. The current stock price of €4.80 is trading 485.4% above its estimated GF Value™ of €0.82. GuruFocus considers Rockwell Medical to be Significantly Overvalued.

Key valuation signals for STU:RWM:

  • Tariff Resilience Score: 6
  • GF Value™: €0.82 vs. price of €4.80 (485.4% above fair value)
  • GF Score™: 26/100 with 3 warning signs

No single metric tells the full story. See the STU:RWM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rockwell Medical Business Description

Other Exchanges RMTI:USARWMA:Germany
Address 30142 South Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
26GF Score

Get the complete analysis for STU:RWM

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.80
Price
€0.82
GF Value